Ulrich Schotten (U.)

van Vreeswijk, N. L., Habibi, Z., van Doorn, S., de Groot, J. R., Stoll, M., Pijnappels, D. A., Heijman, J., Tieleman, R. G., Pisters, R., Hemels, M. E. W., Tjong, F. V. Y., Schotten, U., Rienstra, M., Geersing, G.-J., & Himmelreich, J. C. L. (2026). Atrial cardiomyopathy: from knowledge gaps to clinical impact. Netherlands Heart Journal, 34(11), 399-406. https://doi.org/10.1007/s12471-026-02081-3

Kawczynski, M. J., Gilbers, M. D., Winters, J., Maesen, B., Isaacs, A., Linz, D., Rienstra, M., van Gelder, I., Maessen, J. G., Bidar, E., & Schotten, U. (2026). Circadian patterns of device-detected postoperative atrial fibrillation during 2.5 years of continuous monitoring after cardiac surgery: The RACE V–Tissue Bank Study. Heart Rhythm O2, 7(10), 1884-1899. https://doi.org/10.1016/j.hroo.2026.06.023

Schotten, U., & Kirchhof, P. (2026). Quantifying atrial fibrillation to improve risk estimation: the growing role of AF burden and a new density kid on the block. European Heart Journal, 47(36), 5125-5127. https://doi.org/10.1093/eurheartj/ehag298

Marques, V. G., Gharaviri, A., Pezzuto, S., Guasch, E., Mont, L., Bonizzi, P., Zeemering, S., & Schotten, U. (2026). Analysis of the Effect of Anatomical Variability on Atrial Fibrillation Dynamics Through a Novel Framework for Personalised Atrial Model Generation. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-026-04265-9

Winters, J., Kawczynski, M., Gilbers, M., Isaacs, A., Zeemering, S., Habibi, Z., Rienstra, M., van Gelder, I., Maesen, B., Bidar, E., Verheule, S., & Schotten, U. (2026). Histological evaluation of clinically defined atrial cardiomyopathy stages and their association with atrial fibrillation burden under continuous monitoring for a 2.5-year follow-up. EP Europace, 28(7), Article euag146. https://doi.org/10.1093/europace/euag146

Al-Taie, C., Obergassel, J., Borof, K., Ridder, J., Rillig, A., Metzner, A., Goette, A., Magnussen, C., Sinner, M. F., Sommerfeld, L. C., Willems, S., Zeller, T., Schnabel, R. B., Schotten, U., Zapf, A., Kirchhof, P., & Fabritz, L. (2026). Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study. EP Europace, 28(7), Article euag149. https://doi.org/10.1093/europace/euag149

Ayagama, T., Barrett-Jolley, R., Fischer, R., Hester, S. S., Schotten, U., Verheule, S., & Burton, R. A. B. (2026). Proteomic signatures of mitochondrial dysfunction associated with atrial fibrillation in goats. Scientific Reports, 16(1), Article 28023. https://doi.org/10.1038/s41598-026-58413-1

Baron, D. K., Weberndorfer, V., Crijns, H. J. G. M., Hemels, M. E. W., Tieleman, R. G., de Melis, M., Schotten, U., Linz, D., Van Gelder, I. C., & Rienstra, M. (2026). Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study. American Heart Journal, 296, Article 107366. https://doi.org/10.1016/j.ahj.2026.107366

Baron, D. K., Samuel, M., Crijns, H. J. G. . M., Tieleman, R. G., Hemels, M. E. W., Schotten, U., Linz, D., Van Gelder, I. C., Rienstra, M., & RACE V Investigators (2026). Risk prediction of atrial fibrillation progression in patients with paroxysmal atrial fibrillation: data from the RACE V study. IJC Heart and Vasculature, 64, Article 101932. https://doi.org/10.1016/j.ijcha.2026.101932

Ismaili, D., Virtanen, P., Im, J., Brunnbauer, P., Saleem, U., Sonmez, M. I., Schulz, C., Nandudu, M., Winters, J., Molina, C. E., Petersen, J., Stoll, M., Schotten, U., Hansen, A., Eschenhagen, T., Koivumaki, J. T., & Christ, T. (2026). Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na<SUP>+</SUP>/K<SUP>+</SUP>-ATPase pump current amplitudes. British Journal of Pharmacology, 183(11), 3093-3110. https://doi.org/10.1111/bph.70380